Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06563713
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-02
Brief Title:
A Study to Evaluate the Safety Tolerability Pharmacokinetics and Immunogenicity of STSP-0902 in Healthy Subjects
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1a Randomized Double-Blind Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety Tolerability Pharmacokinetic and Immunogenicity of STSP-0902 in Healthy Subjects
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 1a randomized double-blind placebo-controlled single ascending dose SAD study to evaluate the safety tolerability pharmacokinetics PK and immunogenicity of STSP-0902
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None